Search Orphan Drug Designations and Approvals
-
| Generic Name: | autologous chimeric antigen receptor (CAR) T cells targeting intercellular adhesion molecule-1 (ICAM-1) |
|---|---|
| Date Designated: | 04/09/2019 |
| Orphan Designation: | Treatment of anaplastic thyroid cancer, medullary thyroid cancer, and recurrent or metastatic follicular or papillary thyroid cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
AffyImmune Therapeutics, Inc. 12 Michigan Dr. Natick, Massachusetts 01760 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







